The last 19 months have been filled with many unknowns, and healthcare has been forever impacted because of it. The COVID-19 Delta variant is creating continued challenges, filling ICUs and hospital beds...
Fed’s booster OK too late? Nursing home loses 8 to coronavirus outbreak this fall
By
Alicia Lasek
Nov 17, 2021
A Connecticut nursing home has weathered a facility-wide COVID-19 outbreak that has sickened 89 residents and staff. Booster shots were not yet authorized when the first cases appeared, the operator reports.
Dark night of the sole
By
Gary Tetz
Nov 11, 2021
Maybe I just need to stop reading McKnight’s. That’s the bottom line. Because every time I flip through its pages, whether virtually or in print, I seem to discover researchers have found another horrible...
Multiple factors contribute to COVID-19 vaccine hesitancy among older, ethnic minorities
By
Amy Novotney
Nov 08, 2021
While older adults from minority ethnic backgrounds are at increased risk of contracting and dying from COVID-19, vaccine hesitancy continues to be high among these individuals. In an effort to better...
Protection declines dramatically over time for all three COVID-19 vaccines: study
By
Amy Novotney
Nov 08, 2021
As the delta variant became the dominant strain of coronavirus across the United States, all three COVID-19 vaccines available to Americans lost some of their protective power, with vaccine efficacy among...
LTC docs urge peers to rapidly increase use of COVID-19 antibody drugs
By
Alicia Lasek
Nov 03, 2021
Industry geriatricians have compiled resources for their LTC peers who have not yet come on board with monoclonal antibody treatments. Resident immunity to COVID-19 is declining, and mAbs may prevent hospital...
Long-term care left behind in race to nab COVID monoclonal antibodies: report
Nov 02, 2021
Delayed shipments of antibody doses are putting residents’ lives at risk after federal authorities barred direct orders of the drugs, LTC clinicians say.
Brain fog may last 8 months after bout with COVID-19, patient study finds
By
Alicia Lasek
Oct 25, 2021
Many recovered patients had problems with executive functioning, which can include trouble with organization, listening and attention, as well as processing speed, category fluency, memory encoding, and...
Taking control back
By
Matt Salmon
Oct 19, 2021
I think it’s important that we recognize the impact COVID has had on our staff — and in some cases, recognize the damage it has done. Our staff are experiencing dissatisfaction and disconnection at...
Low-dose aspirin does not reduce adverse heart, lung outcomes in stable COVID patients: study
By
Alicia Lasek
Oct 19, 2021
Contrary to some clinical observations, aspirin and apixaban (Eliquis) do not reduce the rate of major adverse cardiovascular or pulmonary outcomes in stable outpatients with symptomatic COVID-19, researchers...